Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Multiple Myeloma: Epidemiology Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. In 2017, the 8MM had…
DUBLIN–(BUSINESS WIRE)–The “Idiopathic Pulmonary Fibrosis: Competitive Landscape to 2026” report has been added to ResearchAndMarkets.com’s offering. “Idiopathic Pulmonary Fibrosis: Competitive…
FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced that STELLAR-3, a Phase 3, randomized, double-blind, placebo-controlled study evaluating…
PRINCETON, N.J.–(BUSINESS WIRE)–Oyster Point Pharma, Inc., a privately held clinical-stage pharmaceutical company with an initial focus on developing novel therapies…
Strong site relationships key to quality execution, on-time delivery for biopharmaceutical customers WILMINGTON, N.C.–(BUSINESS WIRE)–Pharmaceutical Product Development, LLC (PPD), a…
SAN DIEGO–(BUSINESS WIRE)–Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and…
-FIERCE-21 and FIERCE-22 Phase 2 Trials in Metastatic Bladder Cancer- SAN LEANDRO, Calif.–(BUSINESS WIRE)–Rainier Therapeutics, Inc., a privately-held clinical stage…
Increases First Quarter Revenues 14% to $5.9 Billion Posts First Quarter GAAP EPS of $1.04 and Non-GAAP EPS of $1.10…
US Biopharma Company Undertakes Anti-Cancer Clinical Trials in Poland, First
Patient Showing Positive Initial Treatment
Based on EpimAb’sglobally filed first application, this patent broadly covers bispecificantibodies obtained utilizing the company’s FIT-Ig®technology in a composition of matter claim.